Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The VA formulary, in contrast, is managed by the U.S
D&D Pharmatech
For women who haven't been able to reach their weight goals through diet and exercise alone, GLP-1 medications are one option a healthcare professional, such as a Midi Health clinician, may recommend as part of a broader weight management plan
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
GLP-1 medications generally aren't appropriate with: Personal/family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia type 2 (MEN 2) History of pancreatitis Severe gastroparesis or GI motility disorders Pregnancy, trying to conceive, or breastfeeding A history of eating disorders (requires careful evaluation) Josh reviews your full history at your consult to confirm treatment is safe for you
The surging demand for GLP-1 drugs had previously driven companies like Hims into this multi-billion-dollar market, with many patients willing to pay out-of-pocket
US$ 27.23
US$ 25.23
US$ 27.41
